Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03296306
What this trial is testing

Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma

Who this might be right for
Bladder CancerUreter CancerUrethral Cancer+1 more
Asan Medical Center 330
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Testing effectiveness (Phase 2)UnknownNCT05912205
What this trial is testing

Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation

Who this might be right for
Urothelial Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableLooking for participantsNCT07726602
What this trial is testing

Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
OHSU Knight Cancer Institute 100
Not applicableUnknownNCT03673202
What this trial is testing

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

Who this might be right for
Bladder Cancer
London Health Sciences Centre 300
Early research (Phase 1)Ended earlyNCT00565227
What this trial is testing

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Who this might be right for
Non-Small-Cell Lung CarcinomaProstate CancerBladder Cancer+1 more
University of Michigan Rogel Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01620970
What this trial is testing

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of Bladder
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Not applicableLooking for participantsNCT03973671
What this trial is testing

Prospective Sample Collection for Cancer of Bladder

Who this might be right for
Urinary Bladder Neoplasms
Universitaire Ziekenhuizen KU Leuven 300
Testing effectiveness (Phase 2)Study completedNCT00005644
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT07077447
What this trial is testing

The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
Zealand University Hospital 2,500
Not applicableLooking for participantsNCT07614594
What this trial is testing

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Who this might be right for
Urothelial Carcinoma (UC)Upper Tract Urothelial CarcinomaUTUC+1 more
Henan Provincial People's Hospital 800
Early research (Phase 1)Study completedNCT02720367
What this trial is testing

Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Taris Biomedical LLC 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04180371
What this trial is testing

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Who this might be right for
Advanced Solid Tumor Historically Known for High EphA2 ExpressionUrothelial CancerOvarian Cancer+4 more
BicycleTx Limited 288
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Not applicableLooking for participantsNCT07395037
What this trial is testing

Ward Admissions for Haematuria

Who this might be right for
Urologic DiseasesHematuriaHematuria; Benign+3 more
British Urology Researchers in Surgical Training 1,050
Testing effectiveness (Phase 2)Study completedNCT00526656
What this trial is testing

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT04602078
What this trial is testing

Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
Spanish Oncology Genito-Urinary Group 82
Early research (Phase 1)Looking for participantsNCT06586255
What this trial is testing

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Abramson Cancer Center at Penn Medicine 10
Not applicableLooking for participantsNCT04970472
What this trial is testing

Bio Clinical Collection of Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder Cancer
University Hospital, Toulouse 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03375307
What this trial is testing

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

Who this might be right for
Advanced Bladder CarcinomaAdvanced Genitourinary System CarcinomaMetastatic Bladder Carcinoma+3 more
National Cancer Institute (NCI) 60
Next Page